中古
发表于 2025-3-28 17:13:51
http://reply.papertrans.cn/63/6226/622579/622579_41.png
Calibrate
发表于 2025-3-28 19:12:50
http://reply.papertrans.cn/63/6226/622579/622579_42.png
BORE
发表于 2025-3-29 02:52:25
http://reply.papertrans.cn/63/6226/622579/622579_43.png
小画像
发表于 2025-3-29 03:11:30
http://reply.papertrans.cn/63/6226/622579/622579_44.png
Assignment
发表于 2025-3-29 07:58:25
http://reply.papertrans.cn/63/6226/622579/622579_45.png
直言不讳
发表于 2025-3-29 13:01:33
Combined Resection Liver Metastases and Peritoneal Metastasesal resection of the metastatic disease has led to a significant improvement in the overall and disease-free survival both in selected patients compared to systemic chemotherapy alone which was previously the standard of care. At the same time, it is not uncommon for peritoneal metastases (PM) and li
geometrician
发表于 2025-3-29 15:54:54
Management of Complications of CRS and HIPECy its relatively high morbidity and mortality compared to other surgical procedures. It takes 3–12 months on an average for the quality of life to return to normal. With standardization of indications, better patient selection, development and implementation of perioperative care pathways and instit
浸软
发表于 2025-3-29 19:43:32
http://reply.papertrans.cn/63/6226/622579/622579_48.png
补角
发表于 2025-3-29 23:57:11
Surgical Management of Recurrent Epithelial Ovarian Cancer locoregional therapy comprising of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in addition to systemic chemotherapy has produced promising results in the treatment of this condition for which there is no standard therapy and cure is almost impossible. This trea
bizarre
发表于 2025-3-30 05:30:23
http://reply.papertrans.cn/63/6226/622579/622579_50.png